scholarly journals Modification of the clastogenic effects of cadmium in rat bone marrow with the melaxen

Author(s):  
Ф.Т. Чшиева ◽  
Т.В. Чшиев ◽  
Р.И. Кокаев

При хроническом применении мелаксена в дозе 10 мг/кг индукции генотоксических эффектов в костном мозге крыс не выявлено. Метафазный анализ после хронического совместного внутрижелудочного введения соли кадмия 0,3 мг/кг (в пересчете на металл) и мелаксена показал протекторные свойства последнего (р<0,01). There was no reveled induction of genotoxic effects in rat bone marrow at the constant use of “melaxen” at a dose of 10 mg/kg. The chronic joint intragastric injection of a cadmium salt of 0.3 mg / kg (in terms of metal) and “melaxen “ showed the protective properties of the remedy (p<0.01) after metaphase analysis.

2010 ◽  
Vol 48 (1) ◽  
pp. 209-214 ◽  
Author(s):  
Dimitris Vlastos ◽  
Hariklia Moshou ◽  
Klimentini Epeoglou

2013 ◽  
Vol 31 (3) ◽  
pp. 189-191 ◽  
Author(s):  
Harutyunyan Tigran ◽  
◽  
Karapetyan Anna ◽  
Hovhannisyan Galina ◽  
Aroutiounian Rouben

2004 ◽  
Vol 4 ◽  
pp. 48-54 ◽  
Author(s):  
George Demsia ◽  
Dimitris Vlastos ◽  
Demetrios P. Matthopoulos

Aiming to investigate the possibility of electromagnetic fields (EMF) developed by nonionizing radiation to be a noxious agent capable of inducing genotoxicity to humans, in the current study we have investigated the effect of 910-MHz EMF in rat bone marrow. Rats were exposed daily for 2 h over a period of 30 consecutive days. Studying bone marrow smears from EMF-exposed and sham-exposed animals, we observed an almost threefold increase of micronuclei (MN) in polychromatic erythrocytes (PCEs) after EMF exposure. An induction of MN was also observed in polymorphonuclear cells. The induction of MN in female rats was less than that in male rats. The results indicate that 910-MHz EMF could be considered as a noxious agent capable of producing genotoxic effects.


Author(s):  
A. Balasubramanyam ◽  
N. Sailaja ◽  
M. Mahboob ◽  
M.F. Rahman ◽  
S. Misra ◽  
...  

CYTOLOGIA ◽  
1999 ◽  
Vol 64 (3) ◽  
pp. 277-283 ◽  
Author(s):  
H. B. Ila ◽  
M. Topaktas

2018 ◽  
Vol 18 ◽  
Author(s):  
Chaitra Venugopal ◽  
Christopher Shamir ◽  
Sivapriya Senthilkumar ◽  
Janitri Venkatachala Babu ◽  
Peedikayil Kurien Sonu ◽  
...  

2019 ◽  
Vol 19 (14) ◽  
pp. 1695-1702 ◽  
Author(s):  
Mohsen Cheki ◽  
Salman Jafari ◽  
Masoud Najafi ◽  
Aziz Mahmoudzadeh

Background and Objective: Glucosamine is a widely prescribed dietary supplement used in the treatment of osteoarthritis. In the present study, the chemoprotectant ability of glucosamine was evaluated against cisplatin-induced genotoxicity and cytotoxicity in rat bone marrow cells. Methods: Glucosamine was orally administrated to rats at doses of 75 and 150 mg/kg body weight for seven consecutive days. On the seventh day, the rats were treated with a single injection of cisplatin (5 mg/kg, i.p.) at 1h after the last oral administration. The cisplatin antagonistic potential of glucosamine was assessed by micronucleus assay, Reactive Oxygen Species (ROS) level analysis, hematological analysis, and flow cytometry. Results: Glucosamine administration to cisplatin-treated rats significantly decreased the frequencies of Micronucleated Polychromatic Erythrocytes (MnPCEs) and Micronucleated Normchromatic Erythrocytes (MnNCEs), and also increased PCE/(PCE+NCE) ratio in bone marrow cells. Furthermore, treatment of rats with glucosamine before cisplatin significantly inhibited apoptosis, necrosis and ROS generation in bone marrow cells, and also increased red blood cells count in peripheral blood. Conclusion: This study shows glucosamine to be a new effective chemoprotector against cisplatin-induced DNA damage and apoptosis in rat bone marrow cells. The results of this study may be helpful in reducing the harmful effects of cisplatin-based chemotherapy in the future.


Sign in / Sign up

Export Citation Format

Share Document